Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAR-T Re-treatment for r/r MM
NCT03672253Phase 1Unknown
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jul 2018
- Primary completion
- Dec 2020
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of LCAR-BCDR cells in multiple myeloma (MM), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Occurrence of treatment related adverse events. Status: unknown.
02
Drugs
LCAR-BCDR cells
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03672253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03672253.